4//SEC Filing
WEST MICHAEL D 4
Accession 0001209191-22-036809
CIK 0001708599other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 7:14 PM ET
Size
8.7 KB
Accession
0001209191-22-036809
Insider Transaction Report
Form 4
WEST MICHAEL D
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock, $0.0001 par value
2022-06-11$0.77/sh−1,081$833→ 42,459 total - Exercise/Conversion
Restricted Stock Units
2022-06-11−3,125→ 9,375 totalExercise: $0.00→ Common Stock (3,125 underlying) - Exercise/Conversion
Common Stock, $0.0001 par value
2022-06-11+3,125→ 43,540 total
Footnotes (2)
- [F1]Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4.
- [F2]Restricted Stock Units vested on June 11, 2022.
Documents
Issuer
AgeX Therapeutics, Inc.
CIK 0001708599
Entity typeother
Related Parties
1- filerCIK 0001202529
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 7:14 PM ET
- Size
- 8.7 KB